Cancer News and Research

Latest Cancer News and Research

Highly advanced imaging method helps to monitor rapid changes in glutathione redox potentials in live cells

Highly advanced imaging method helps to monitor rapid changes in glutathione redox potentials in live cells

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

Study sheds light on tiny environments that stem cells occupy in animal bodies

Study sheds light on tiny environments that stem cells occupy in animal bodies

Benzodiazepines may contribute to respiratory problems in people with COPD

Benzodiazepines may contribute to respiratory problems in people with COPD

Research roundup: Colonscopy in the countryside; retiree health benefits; what should hip surgery cost?

Research roundup: Colonscopy in the countryside; retiree health benefits; what should hip surgery cost?

Research: Drugs used to treat lung, breast and pancreatic cancers promote drug-resistance, spur tumor growth

Research: Drugs used to treat lung, breast and pancreatic cancers promote drug-resistance, spur tumor growth

Stanford researchers identify normal cell type that gives rise to most invasive bladder cancers

Stanford researchers identify normal cell type that gives rise to most invasive bladder cancers

Twenty years data analysis shows patients treated with HIPEC may have improved survival rates

Twenty years data analysis shows patients treated with HIPEC may have improved survival rates

Researchers receive $3.7M NIH grant to develop anti-smoking program for HIV-infected smoker

Researchers receive $3.7M NIH grant to develop anti-smoking program for HIV-infected smoker

Researchers devise new approach to treatment of Alzheimer's disease

Researchers devise new approach to treatment of Alzheimer's disease

Researchers reveal connection between Down syndrome and acute lymphoblastic leukemia

Researchers reveal connection between Down syndrome and acute lymphoblastic leukemia

At 8 million sign-ups, health law enrollment surpasses target

At 8 million sign-ups, health law enrollment surpasses target

Pfizer to highlight Blue Button initiative at DIA 2014 Annual Meeting in San Diego

Pfizer to highlight Blue Button initiative at DIA 2014 Annual Meeting in San Diego

Olympus' surgical products named finalists for ATA award

Olympus' surgical products named finalists for ATA award

WOTV 4's Maranda and Forest Hills Central students honored for contributing to community-based causes

WOTV 4's Maranda and Forest Hills Central students honored for contributing to community-based causes

Viewpoints: Obamacare still has more challenges; GOP needs to help make law work; census change is not Obama's decision

Viewpoints: Obamacare still has more challenges; GOP needs to help make law work; census change is not Obama's decision

Cyclenium Pharma signs drug discovery and development agreement with Southern Research Institute

Cyclenium Pharma signs drug discovery and development agreement with Southern Research Institute

Drug used to treat TB may also act against various infections, says study

Drug used to treat TB may also act against various infections, says study

Engineering cell-based, biological devices may selectively kill cancer cells without disrupting healthy cells

Engineering cell-based, biological devices may selectively kill cancer cells without disrupting healthy cells

Men with chronic inflammation in non-cancerous prostate tissue may have nearly twice risk of prostate cancer

Men with chronic inflammation in non-cancerous prostate tissue may have nearly twice risk of prostate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.